Skip to content
Peptigraph home

MOTS-c Price: Cost per mg and per Week

What MOTS-c costs per mg by vial size, from dated public listings. No vendor links, no coupons.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureMitochondrial-derived peptideUpdated
Data only. We never link to sellers, take commissions on peptide sales or publish coupon codes.

Price per mg

No price index for MOTS-c yet. We publish prices only as an aggregate of dated listings we have re-checked, and we have not collected enough for MOTS-c. We would rather show nothing than a guess.

Why prices vary

  • Research-use products are unregulated, so a low price can mean less active peptide than the label says.
  • Bigger vials usually cost less per mg, but only if the whole vial is used before it expires.
  • Prices change often, which is why every figure here carries the date it was checked.

Common questions

How much does MOTS-c cost?

We publish price per mg only from dated, public listings. We have not collected enough listings for MOTS-c to publish a figure. We never link to sellers.

Where can I buy MOTS-c?

We don't link to or recommend sellers. MOTS-c is not an approved drug, and research-use products are not checked by the FDA for identity, purity or dose.

More on MOTS-c

Sources

  1. 1Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2; 'nominated but withdrawn' table, content current as of 22 Apr 2026)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  2. 2Pharmacy Compounding Advisory Committee meeting, 23–24 Jul 2026 (agenda and materials)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  3. 3World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  4. 4United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "MOTS-c" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  5. 5US compounding: MOTS-c was removed from FDA's 503A category 2 after the nominator withdrew; FDA announced a PCAC consultation on 23 July 2026.U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026

Found an error? Report a correction.